{"id":"W2091130375","doi":"10.1517/13543780903066772","title":"EGFR-directed therapies to treat non-small-cell lung cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lung cancer; Medicine; Tyrosine kinase; Cancer research; Cancer; Angiogenesis; Epidermal growth factor receptor; Monoclonal antibody; Disease; Drug development; Targeted therapy; Drug; Oncology; Immunology; Pharmacology; Internal medicine; Receptor; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005712909,0.000852693,0.001391301,0.00160812,0.0002475938,0.0005721584,0.0008773921,0.001038382,0.005840158],"category_scores_gemma":[0.0003455214,0.0002171822,0.000573799,0.001256178,0.0003452415,0.0008617407,0.0004725363,0.001786513,0.005698252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005144015,"about_ca_system_score_gemma":0.0005989227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000805355,"about_ca_topic_score_gemma":0.002634891,"domain_scores_codex":[0.9998227,0.00003068148,0.00001553711,0.00002413767,0.00008940411,0.00001769828],"domain_scores_gemma":[0.9998665,0.00004510134,0.00002524295,0.000005839105,0.00004031635,0.00001695262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007547272,0.0002156419,0.0001099085,0.006647293,0.00008572006,0.0003686828,0.00004542479,0.0003200381,0.005307849,0.002535795,0.03304886,0.9512393],"study_design_scores_gemma":[0.0001070415,0.0002624924,0.0007508482,0.001666303,0.00008636562,0.002323656,0.00003881889,0.0001075018,0.001230193,0.001472782,0.9919355,0.00001847655],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003420625,0.9935884,0.0004252391,0.00062562,0.0003568473,0.00003252112,0.0000346426,0.00001917504,0.004575338],"genre_scores_gemma":[0.001373426,0.9947191,0.0006324176,0.0004879569,0.0002279107,0.00002649741,0.00007085261,0.000003227786,0.002458641],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005840158,"threshold_uncertainty_score":0.01953727,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04626132764116791,"score_gpt":0.3999452614262695,"score_spread":0.3536839337851016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}